Overview Efficacy of Lu 31-130 in Patients With Schizophrenia Status: Completed Trial end date: 2009-11-01 Target enrollment: Participant gender: Summary The main purpose with the study is to evaluate the efficacy and safety of Lu 31-130 in patients suffering from schizophrenia compared to placebo. Phase: Phase 2 Details Lead Sponsor: H. Lundbeck A/S